Elotuzumab in Combination with Lenalidomide and Dexamethasone for Treatment-resistant Immunoglobulin Light Chain Amyloidosis With Multiple Myeloma

Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

Sagar Lonial, Meletios Α. Dimopoulos, Antonio Palumbo et al. · New England Journal of Medicine · 2015 · 1.3K citations · Full text

Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989 [see comments]

RA Kyle, Athena Linos, C. Mary Beard et al. · Blood · 1992 · 631 citations · Full text

Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation.

William E. Klunk, Jay W. Pettegrew, Donald J. Abraham · Journal of Histochemistry & Cytochemistry · 1989 · 618 citations · Full text

Insulin Fibrils, Quantitative Evaluation, Protein Chemistry +15

A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis

Giovanni Palladini, Sajitha Sachchithanantham, Paolo Milani et al. · Blood · 2015 · 430 citations · Full text

Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis

Joseph Mıkhael, Steven R. Schuster, Víctor H. Jiménez‐Zepeda et al. · Blood · 2012 · 373 citations · Full text